Mangalam Drugs & Organics logo

Mangalam Drugs & Organics

MANGALAM NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹55.08 Cr
Volatility
High Risk
P/E Ratio
-1.4
EBITDA
₹-14.91 Cr
Return on Equity
4.51%
Debt to Equity
1.02
Book Value
₹60.64
52W High
₹79.49
52W Low
₹22.8

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Stock is trading at 0.56 times its book value

Weaknesses

7
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -9.39% over past five years.
  • Promoter holding is low: 35.6%
  • Company has a low return on equity of -11.0% over last 3 years.
  • Contingent liabilities of Rs.34.6 Cr.
  • Debtor days have increased from 45.3 to 63.4 days.
  • Promoter holding has decreased over last 3 years: -14.7%

Growth Rate

Revenue Growth
-27.16% lower than 3Y
Net Income Growth
-829% lower than 3Y
Cash Flow Change
989%
ROE
-168% lower than 3Y
ROCE
571% level than 3Y
EBITDA Margin (Avg.)
-156% higher than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
87.46
81.56
97.34
102
76.53
79.94
88.71
72.78
57.21
49.54
58.38
67.29
57.12
Expenses
90.94
79.37
90.36
90.54
68.34
71.25
79.94
62.88
61.86
52.37
59.96
72.65
56.22
Operating Profit
-3.48
2.19
6.98
11.7
8.19
8.69
8.77
9.9
-4.65
-2.83
-1.58
-5.36
0.9
OPM %
-3.98%
2.69%
7.17%
11.44%
10.7%
10.87%
9.89%
13.6%
-8.13%
-5.71%
-2.71%
-7.97%
1.58%
Other Income
0.02
0.03
0
0.05
0.02
0.14
0.13
0.47
0.14
0.03
0.22
0.09
0.11
Interest
3.41
3.24
3.31
3.95
3.75
3.67
3.49
4.03
4.04
5.03
4.05
3.08
3.68
Depreciation
3.42
3.73
3.62
3.86
3.87
3.97
3.93
4.61
4.38
4.53
4.37
4.56
3.99
PBT
-10.29
-4.75
0.05
3.94
0.59
1.19
1.48
1.73
-12.93
-12.36
-9.78
-12.91
-6.66
Tax %
-7.29%
-25.05%
-920%
9.9%
-355.93%
-125.21%
5.41%
90.75%
6.19%
-41.42%
0%
1.16%
13.36%
Net Profit
-9.54
-3.56
0.5
3.55
2.68
2.69
1.4
0.15
-13.73
-7.25
-9.78
-13.06
-7.55
EPS in Rs
-6.03
-2.25
0.32
2.24
1.69
1.7
0.88
0.09
-8.67
-4.58
-6.18
-8.25
-4.77
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
221
295
299
269
228
282
380
451
372
369
318
232
232
Expenses
200
257
252
222
218
259
327
402
347
351
282
247
241
Operating Profit
20
38
47
47
10
24
53
49
26
17
36
-15
-9
OPM %
9%
13%
16%
17%
4.3%
8%
14%
11%
7%
4.7%
11%
-6%
-3.8%
Other Income
0
0
0
1
0
1
5
0
0
0
0
1
0
Interest
10
9
10
12
9
10
9
11
13
14
15
16
16
Depreciation
4
4
5
7
7
8
9
10
11
15
16
18
17
PBT
6
24
31
29
-6
6
40
28
2
-11
5
-48
-42
Tax %
-2%
33%
29%
32%
40%
-32%
29%
29%
43%
-18%
-39%
-9%
—
Net Profit
6
16
22
20
-8
8
28
20
1
-9
7
-44
-38
EPS in Rs
4.66
11.15
14.08
12.57
-5.07
5.21
17.67
12.42
0.8
-5.72
4.37
-27.68
-23.78
Div. Payout %
0%
0%
0%
4%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
13
14
16
16
16
16
16
16
16
16
16
16
Reserves
16
47
70
88
80
88
115
135
136
127
133
87
Borrowings
78
60
66
69
65
52
70
88
89
107
96
105
Other Liabilities
63
38
38
54
50
75
64
90
117
108
114
99
Total Liabilities
170
160
190
227
211
231
264
328
358
357
359
308
Fixed Assets
53
54
93
102
103
101
118
135
142
147
156
152
CWIP
0
5
0
0
0
1
6
6
9
8
3
0
Investments
0
0
2
0
0
0
0
0
0
0
0
0
Other Assets
117
100
95
125
107
128
140
188
206
202
201
156
Total Assets
170
160
190
227
211
231
264
328
358
357
359
308
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
14
22
43
25
22
31
28
26
38
12
43
4
Investing
-4
-11
-39
-16
-9
-7
-31
-27
-22
-18
-19
-12
Financing
-10
-11
-3
-9
-11
-23
3
3
-17
6
-22
6
Net Cash Flow
1
0
0
0
1
0
-1
1
-1
0
2
-2
Free Cash Flow
10
11
3
9
12
24
-4
-2
16
-6
23
-8
CFO/OP
69
68
107
66
223
129
69
70
148
71
119
-30
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
73
37
45
61
28
52
52
38
46
28
45
63
Inventory Days
134
85
69
132
175
121
85
139
200
185
303
239
Days Payable
128
37
38
82
77
106
63
65
139
124
199
160
Cash Conversion Cycle
79
85
75
111
126
67
74
112
107
88
148
142
Working Capital Days
26
32
19
31
21
10
23
43
38
18
13
-54
ROCE %
16%
29%
31%
25%
2%
11%
27%
18%
6%
1%
8%
-14%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Mangalam Drugs & Organics insights

65 extracted metrics + investor summaries across FY05–FY26.

Log in — free

Shareholding Pattern

FIIs0.11%Public60.51%Others3.73%Promot.35.65%As ofJun 2026

Documents

Frequently Asked Questions about Mangalam Drugs & Organics

What does Mangalam Drugs and Organics Ltd do?
Incorporated in 1977, Mangalam Drugs & Organics Ltd manufactures Active Pharmaceutical Ingredients and Intermediates.[1]
Where is Mangalam Drugs and Organics Ltd (MANGALAM) listed?
Mangalam Drugs and Organics Ltd trades as MANGALAM on the NSE and under code 532637 on the BSE.
Which sector does Mangalam Drugs and Organics Ltd belong to?
Mangalam Drugs and Organics Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Mangalam Drugs and Organics Ltd?
Mangalam Drugs and Organics Ltd has a market capitalisation of ₹55.08 Cr, which places it in the Small Cap band.
What is the PE ratio of Mangalam Drugs and Organics Ltd?
Mangalam Drugs and Organics Ltd trades at a PE ratio of -1.40, against a book value of ₹60.64 per share.
What is the 52-week high and low of Mangalam Drugs and Organics Ltd?
Over the last 52 weeks Mangalam Drugs and Organics Ltd has traded between ₹22.8 and ₹79.49.
What is the Return on Equity (ROE) of Mangalam Drugs and Organics Ltd?
Mangalam Drugs and Organics Ltd reported a return on equity of 4.51%. Its debt-to-equity ratio is 1.02.

Company Information

Incorporated in 1977, Mangalam Drugs & Organics Ltd manufactures Active Pharmaceutical Ingredients and Intermediates.[1]

Website mangalamdrugs.com
Listed 2005-05-23
Face Value ₹ 10
Issued Size 1,58,28,248

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/MANGALAM.md for Mangalam Drugs and Organics Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List